ANNALEE MATTHEWS: Open Payments
NPI 1386315232 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,735 in 193 payments from 19 companies in 2025. Trend: 2023 $4,583 · 2024 $7,312 · 2025 $4,735
Food & beverage: $4,722Education: $13
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 39 | $819 |
| Regeneron Healthcare Solutions, Inc. | 25 | $808 |
| ABBVIE INC. | 39 | $543 |
| Incyte Corporation | 16 | $512 |
| GENZYME CORPORATION | 13 | $386 |
| Galderma Laboratories, L.P. | 8 | $371 |
| UCB, Inc. | 15 | $237 |
| Amgen Inc. | 7 | $217 |
| Organon LLC | 6 | $148 |
| Organogenesis Inc. | 1 | $137 |
Products named: DUPIXENT, TREMFYA, OPZELURA, NEMLUVIO, SKYRIZI, RINVOQ, Bimzelx, Otezla.
Industry payments across GA — which companies pay providers there.
